Premium Endoscopy Package (M/F)

US$1,402
NT$45,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Good Liver Health Management Center on 02-2388-8799 / 0800-000-582 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

An executive-tier program with Coronary artery calcium score, Low-dose chest CT, Colonoscopy, Gastroscopy (upper GI endoscopy) and Abdominal ultrasound and a 73-test panel.

Lead time
30 days
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Colonoscopy

Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.

Gastroscopy (upper GI endoscopy)

Stomach and esophagus ulcers, inflammation and cancer.

Every test, in English

73 tests listed, 64 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count3
Liver Function8
Kidney & Electrolytes6
Lipids & Cardiometabolic5
Glucose3
Thyroid & Endocrine2
Tumor Markers6
Infection Serology4
Urine & Stool2
Cardiac2
X-ray1
Ultrasound6
CT Imaging2
Endoscopy2
Women's Health2
Bone & Body Composition1
Eye4
Show all 73 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Rheumatoid factor (RF)A marker associated with rheumatoid arthritis.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
AmylasePancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
LipasePancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubinJaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CalciumBone, parathyroid and kidney conditions.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioA calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterolProtective cholesterol level.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Fasting insulinInsulin resistance.
Thyroid & Endocrine
Free T4Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 15-3Breast cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
PSAProstate cancer marker.
Infection Serology
Hepatitis A antibodyImmunity to hepatitis A.
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Urine microalbumin / ACREarly kidney damage, especially in diabetes and hypertension.
Cardiac
10-year cardiovascular risk scoreA calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECGHeart rhythm and signs of prior heart damage.
X-ray
Chest X-rayLung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Carotid ultrasoundPlaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundProstate size and abnormalities.
Thyroid ultrasoundThyroid nodules.
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Endoscopy
ColonoscopyColon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
MammographyBreast cancer; the standard screen for women 40+.
Pap smearCervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Retinal (fundus) photographyDiabetic and hypertensive eye damage, macular degeneration.
Intraocular pressureGlaucoma.
Retinal OCTDetailed retina and optic nerve imaging; glaucoma and macular disease.
Visual acuityVision sharpness.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Rheumatoid factor (RF)
A marker associated with rheumatoid arthritis.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
Amylase
Pancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Lipase
Pancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubin
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Calcium
Bone, parathyroid and kidney conditions.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Electrolytes (Na, K, Cl)
Salt and fluid balance; kidney and hormone problems.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratio
A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterol
Protective cholesterol level.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Fasting insulin
Insulin resistance.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 15-3
Breast cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis A antibody
Immunity to hepatitis A.
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Urine microalbumin / ACR
Early kidney damage, especially in diabetes and hypertension.
Cardiac
10-year cardiovascular risk score
A calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECG
Heart rhythm and signs of prior heart damage.
X-ray
Chest X-ray
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasound
Plaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasound
Prostate size and abnormalities.
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Coronary artery calcium score
Calcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CT
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Endoscopy
Colonoscopy
Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)
Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
Mammography
Breast cancer; the standard screen for women 40+.
Pap smear
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Retinal (fundus) photography
Diabetic and hypertensive eye damage, macular degeneration.
Intraocular pressure
Glaucoma.
Retinal OCT
Detailed retina and optic nerve imaging; glaucoma and macular disease.
Visual acuity
Vision sharpness.
Also listed: ALT (GPT), AST (GOT), Basic hearing test, Health checkup physical examination, Metabolic syndrome screening, Pancreatic elastase-1, Sedation (gastroscopy and colonoscopy), Urine chemistry panel, Urine protein.

Before you book

Booking lead time30 days
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Good Liver Health Management Center
Taipei · Zhongzheng

10 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Extra costs
  • If a polyp is treated during the gastroscopy or colonoscopy, an extra fee for the procedure and materials applies, paid on the day; for a colon polyp removal, patients may choose whether to claim it through NHI or pay out of pocket.

    Source ↗ · checked 2026-09-22

  • The center's single-procedure sedation (painless endoscopy) fee is NT$3,500.

    Source ↗ · checked 2026-09-22

  • The center's two-procedure sedation (painless endoscopy) fee is NT$5,700.

    Source ↗ · checked 2026-09-22

Booking and payment
  • The center recommends booking the health checkup at least one month before the desired exam date.

    Source ↗ · checked 2026-09-22

  • A patient who wants to switch to a different checkup package must tell the center at least 7 days before the exam.

    Source ↗ · checked 2026-09-22

  • Rescheduling or cancelling a high-end imaging exam (CT or MRI) must be requested at least 7 working days before the exam date.

    Source ↗ · checked 2026-09-22

  • If the pre-checkup packet and bowel-prep medication have already been mailed out, cancelling the checkup afterward means the center charges for the bowel-prep medication.

    Source ↗ · checked 2026-09-22

  • On the day of the checkup, patients can pay by cash or credit card.

    Source ↗ · checked 2026-09-22

Before and on the day
  • After booking, patients must complete an online health questionnaire before checking in at the center, submitting it by clicking Submit to finish.

    Source ↗ · checked 2026-09-22

  • The center says only fasting blood glucose, cholesterol and triglyceride tests require fasting; other tests do not require strict fasting, and a moderate amount of plain water is allowed during the fasting period.

    Source ↗ · checked 2026-09-22

Results
  • As of 2026-02-01, the center no longer automatically provides an image CD for in-house exam items; if a patient needs one for a visit to another clinic, they can call to request one, which is provided free of charge.

    Source ↗ · checked 2026-09-22

  • For high-end imaging done at partner hospitals (such as CT or MRI), the center always provides the full image CD along with a paper report.

    Source ↗ · checked 2026-09-22

  • The center gives patients a full paper report and also offers its own app, where patients can see the complete report, view imaging pictures with the physician's English-language interpretation for imaging studies, and download the whole report as a PDF.

    Source ↗ · checked 2026-09-22

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
Antinuclear antibody (ANA)
US$17
NT$550
Iron studiesas listed: Iron studies (serum iron, ferritin, TIBC)
US$28
NT$900
serum iron, ferritin, TIBC
High-sensitivity CRPas listed: High-sensitivity C-reactive protein (hs-CRP)
US$16
NT$500
Homocysteine
US$25
NT$800
Vitamin D (25-OH)as listed: Vitamin D test
US$29
NT$920
H. pylori stool antigenas listed: Stool H. pylori antigen test
US$16
NT$500
H. pylori urea breath testas listed: Carbon-13 urea breath test (C13-UBT)
US$47
NT$1,500
Echocardiogramas listed: Cardiac color Doppler ultrasound (echocardiogram)
US$125
NT$4,000
Spine X-rayas listed: Cervical spine X-ray (AP + lateral)
US$19
NT$600
Liver elastography (FibroScan)as listed: Liver fibrosis scan (FibroScan)
US$37
NT$1,200
Coronary CT angiographyas listed: Coronary CT angiography (with contrast)
US$623
NT$20,000
Abdominal MRI / MRCPas listed: Abdominal MRI (without contrast)
US$312
NT$10,000

Source ↗ · checked 2026-09-22

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$7,613–11,187 for a woman (60 of 62 tests) and US$7,357–10,699 for a man (56 of 58 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 3.6 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.2 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 9 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Low-dose chest CT · about 1.5 mSv
  • Mammography · about 0.28 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 30 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 19 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Colonoscopy

Usually needs a clear-liquid diet the day before and a split-dose bowel-cleansing prep taken the evening before and morning of the exam; drinking extra fluids helps avoid dehydration.

Mention when booking: Tell the center about heart, kidney or lung disease, blood thinners, diabetes medicine, aspirin, arthritis medicine or iron; ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, operating machinery or signing legal documents for the rest of the day; someone should take you home.

Gastroscopy (upper GI endoscopy)

Usually needs about 8 hours without food or drink, including water, beforehand.

Mention when booking: Tell the center about heart or lung disease, aspirin, blood thinners, arthritis medicine, insulin or iron, and ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, machinery or legal documents that day; get a ride home. Contact a doctor for fever, trouble swallowing, chest or belly pain, or black stools; bleeding can start days later.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Retinal (fundus) photography

Often done with a camera that photographs the retina without drops; some centers use dilating drops that widen the pupil, which blurs vision for a few hours afterward.

Mention when booking: Mention any eye pain, halos around lights, or a narrow drainage angle or angle-closure glaucoma history.

Afterwards: If drops were used, vision may be blurry and light-sensitive for a few hours; have someone else drive. Sudden eye pain, headache, blurred vision or halos after dilation need urgent care.

Retinal OCT

May or may not need dilating eye drops beforehand; the scan itself takes about 5 to 10 minutes and involves resting your head on a support.

Mention when booking: Mention any eye pain, halos around lights, or a narrow drainage angle or angle-closure glaucoma history.

Afterwards: If drops were used, vision may be blurry and light-sensitive for a few hours; have someone else drive. Sudden eye pain, headache, blurred vision or halos after dilation need urgent care.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Premium Endoscopy Package (M/F)
US$1,402
Book this checkup

If this isn't quite right

Other packages at Good Liver Health Management Center

All packages at Good Liver Health Management Center →

Similar packages in Taipei

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · Stomach and colon · Lung · All checkups in Taipei · What a checkup costs in Taiwan